MDxHealth prices IPO at $12 per American Depositary Share

HERSTAL, BELGIUM: MDxHealth SA, a commercial-stage precision diagnostics company, announced the pricing of its initial public offering (IPO) in the United States of 3.75 million American Depositary Shares (each representing 10 ordinary shares) (“ADSs”) at a price to the public of USD 12.00 per ADS for total gross proceeds of USD 45.0 million.

In connection with the Offering, MDxHealth has granted the underwriters a 30-day option to purchase additional ordinary shares, which may be in the form of ADSs, on the same terms and conditions, representing up to 15% of the total number of ordinary shares (as the case may be, in the form of ADSs) offered in the Offering.

The closing of the Offering is expected to occur on November 8, 2021, subject to the satisfaction of customary closing conditions.

MDxHealth’s ordinary shares are currently listed on Euronext Brussels under the symbol “MDXH”. The ADSs are expected to begin trading on the NASDAQ Capital Market on November 4, 2021 under the symbol “MDXH”.

Piper Sandler and Oppenheimer & Co. Inc. are acting as lead book-running managers, BTIG is acting as a lead manager, and KBC Securities USA is acting as a co-manager for the Offering.